CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 261 enrolled
Drug / intervention
Placed ECOM endotracheal cardiac output monitor in patients undergoing cardiac surgerydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00924482
NCT00924482Phase 3Completed
CompareCT.gov

Impedance Cardiography: Clinical Evaluation of Endotracheal Cardiac Output Monitor (ECOM)

University of California, San Francisco·interventional·Posted Jun 19, 2009·Updated Nov 28, 2023

In Brief

A Phase 3 clinical trial evaluating Placed ECOM endotracheal cardiac output monitor in patients undergoing cardiac surgery for Cardiac Output. Completed, enrolled 261 participants.

Detailed Summary

1. Compare measurements of cardiac output derived from electrical measurements from electrodes on an endotracheal tube (ECOM or Endotracheal Cardiac Output Monitor) to those made from a pulmonary artery thermodilution catheter. 2. Establish the safety and efficacy of the ECOM system.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Output
Countries--
CollaboratorsCONMED Corporation

Timeline

Phase 3CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 19, 2009
Enrollment StartJan 1, 2007
Primary CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 17.0 years ago

Interventions

Placed ECOM endotracheal cardiac output monitor in patients undergoing cardiac surgerydevice

Measure cardiac output during perioperative period and compare to pulmonary artery thermodilution cardiac output measurements.